Tumor Models Global Market Report 2025

Description

Tumor models are experimental biological systems designed to replicate the characteristics and behavior of tumors in living organisms. They aim to mimic the cellular makeup, molecular features, growth patterns, and interactions with the surrounding environment. These models enable researchers to study tumor development and progression under controlled conditions, facilitating a deeper understanding of cancer biology.

The primary types of tumor models include primary tumor models, metastatic tumor models, orthotopic tumor models, and heterotopic tumor models. Primary tumor models are experimental tumors created by implanting or inducing cancer cells at the site where the tumor naturally originates. These models are applied in drug discovery and development, cancer research, personalized medicine, and toxicology studies. Various technologies are employed, including xenograft models, genetically engineered mouse models (GEMMs), three-dimensional (3D) tumor spheroids, and organ-on-a-chip systems. End users include pharmaceutical and biotechnology companies, academic institutions, contract research organizations (CROs), and government research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The tumor models market research report is one of a series of new reports from The Business Research Company that provides tumor models market statistics, including tumor models industry global market size, regional shares, competitors with a tumor models market share, tumor models market segments, market trends and opportunities, and any further data you may need to thrive in the tumor models industry. This tumor models market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor model market size has grown rapidly in recent years. It will grow from $1.92 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to the rising incidence of cancer, increasing demand for personalized medicine, the growing need for improved preclinical predictability, expanded use of patient-derived xenograft models, and a heightened reliance on in vivo efficacy data.

The tumor model market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to an increasing focus on human-relevant models, rising demand for precision oncology, growth in immuno-oncology, expanding need for high-throughput screening models, and heightened interest in rare cancer models. Major trends in the forecast period include the development of three-dimensional (3D) cell culture models, advancements in pharmaceutical research and development, improvements in cell culture technologies, integration of AI in cancer modeling, and the development of patient-derived organoids.

The increasing demand for personalized medicine is expected to drive growth in the tumor models market in the coming years. Personalized medicine is a healthcare approach that leverages information about an individual's genes and lifestyle to tailor treatments and care to their specific needs. This rising demand is fueled by people's preference for health technologies that provide real-time monitoring and personalized treatment plans. Tumor models support personalized medicine by allowing researchers and clinicians to test and predict how a patient's tumor will respond to specific therapies, serving as experimental platforms that mimic the behavior of real human cancers and enabling more targeted treatment strategies. For example, according to the Personalized Medicine Coalition, a US-based professional membership organization, the approval of 12 new personalized medicines in 2022 accounted for approximately 34% of all newly approved therapies, reflecting a substantial increase from previous years. Consequently, the growing demand for personalized medicine is driving the tumor models market.

Key players in the tumor models market are developing advanced solutions, such as tumor spheroid models, to improve the physiological relevance and predictive accuracy of in vitro cancer models. Tumor spheroid models are three-dimensional (3D) aggregates of cancer cells that naturally form spherical structures in culture. For instance, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, launched new 3D cell technology to accelerate cancer drug discovery. The platform offers advanced 3D tumor spheroid and organoid models that closely mimic the tumor microenvironment, high-throughput screening for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics to enhance predictive accuracy and provide deeper insights into therapeutic responses.

In October 2024, Merck & Co. Inc., a US-based pharmaceutical company, acquired Modifi Biosciences for an undisclosed amount. Through this acquisition, Merck aims to strengthen its oncology portfolio by incorporating Modifi's novel small-molecule therapies, which selectively target cancer cells with DNA repair deficiencies, particularly in hard-to-treat tumors such as glioblastomas. Modifi Biosciences Inc., based in the US, specializes in tumor models.

Major players in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tumor models market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor models market includes revenues earned by entities by providing services such as drug screening and efficacy testing, tumor biology research, biomarker discovery and validation, toxicology and safety testing, and immuno-oncology studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor models market also includes sales of cancer cell lines, in vitro tumor models, imaging systems, tumor model kits, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Models Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor models market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor models ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor models market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type Of Tumor: Primary Tumor Models; Metastatic Tumor Models; Orthotopic Tumor Models; Heterotopic Tumor Models
2) By Application: Drug Discovery And Development; Cancer Research; Personalized Medicine; Toxicology Studies
3) By Technology: Xenograft Models; Genetically Engineered Mouse Models (GEMMs); Three-Dimensional (3D) Tumor Spheroids; Organ-On-A-Chip Models
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic Institutions; Contract Research Organizations (CROs); Government Research Organizations
Subsegments:
1) By Primary Tumor Models: Carcinoma Models; Sarcoma Models; Glioma Models; Melanoma Models; Leukemia Models; Lymphoma Models
2) By Metastatic Tumor Models: Lung Metastasis Models; Bone Metastasis Models; Liver Metastasis Models; Brain Metastasis Models; Lymph Node Metastasis Models
3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models; Orthotopic Lung Cancer Models; Orthotopic Pancreatic Cancer Models; Orthotopic Colon Cancer Models; Orthotopic Prostate Cancer Models
4) By Heterotopic Tumor Models: Subcutaneous Tumor Models; Intramuscular Tumor Models; Intraperitoneal Tumor Models
Companies Mentioned: Merck & Co Inc.; LabCorp Holdings Inc.; Eurofins Scientific SE; WuXi AppTec Co Ltd.; Charles River Laboratories International Inc.; PerkinElmer Inc.; Pharmaron Beijing Co. Ltd.; The Jackson Laboratory; Taconic Biosciences Inc.; Cyagen Biosciences Inc.; Crown Bioscience Inc.; Champions Oncology Inc.; Reaction Biology Corporation; InSphero AG; Creative Biolabs Inc.; Oncodesign S.A.; Xentech S.A.; MIMETAS BV; Experimental Pharmacology and Oncology Berlin-Buch GmbH; Hera BioLabs Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37912

1. Executive Summary

2. Tumor Models Market Characteristics

3. Tumor Models Market Trends And Strategies

4. Tumor Models Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Models Growth Analysis And Strategic Analysis Framework

5.1. Global Tumor Models PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tumor Models Market Growth Rate Analysis
5.4. Global Tumor Models Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tumor Models Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tumor Models Total Addressable Market (TAM)

6. Tumor Models Market Segmentation

6.1. Global Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Tumor Models
Metastatic Tumor Models
Orthotopic Tumor Models
Heterotopic Tumor Models
6.2. Global Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery And Development
Cancer Research
Personalized Medicine
Toxicology Studies
6.3. Global Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Xenograft Models
Genetically Engineered Mouse Models (GEMMs)
Three-Dimensional (3D) Tumor Spheroids
Organ-On-A-Chip Models
6.4. Global Tumor Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic Institutions
Contract Research Organizations (CROs)
Government Research Organizations
6.5. Global Tumor Models Market, Sub-Segmentation Of Primary Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carcinoma Models
Sarcoma Models
Glioma Models
Melanoma Models
Leukemia Models
Lymphoma Models
6.6. Global Tumor Models Market, Sub-Segmentation Of Metastatic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Metastasis Models
Bone Metastasis Models
Liver Metastasis Models
Brain Metastasis Models
Lymph Node Metastasis Models
6.7. Global Tumor Models Market, Sub-Segmentation Of Orthotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orthotopic Breast Cancer Models
Orthotopic Lung Cancer Models
Orthotopic Pancreatic Cancer Models
Orthotopic Colon Cancer Models
Orthotopic Prostate Cancer Models
6.8. Global Tumor Models Market, Sub-Segmentation Of Heterotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous Tumor Models
Intramuscular Tumor Models
Intraperitoneal Tumor Models

7. Tumor Models Market Regional And Country Analysis

7.1. Global Tumor Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tumor Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Models Market

8.1. Asia-Pacific Tumor Models Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Models Market

9.1. China Tumor Models Market Overview
9.2. China Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Models Market

10.1. India Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Models Market

11.1. Japan Tumor Models Market Overview
11.2. Japan Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Models Market

12.1. Australia Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Models Market

13.1. Indonesia Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Models Market

14.1. South Korea Tumor Models Market Overview
14.2. South Korea Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Models Market

15.1. Western Europe Tumor Models Market Overview
15.2. Western Europe Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Models Market

16.1. UK Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Models Market

17.1. Germany Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Models Market

18.1. France Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Models Market

19.1. Italy Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Models Market

20.1. Spain Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Models Market

21.1. Eastern Europe Tumor Models Market Overview
21.2. Eastern Europe Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Models Market

22.1. Russia Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Models Market

23.1. North America Tumor Models Market Overview
23.2. North America Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Models Market

24.1. USA Tumor Models Market Overview
24.2. USA Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Models Market

25.1. Canada Tumor Models Market Overview
25.2. Canada Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Models Market

26.1. South America Tumor Models Market Overview
26.2. South America Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Models Market

27.1. Brazil Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Models Market

28.1. Middle East Tumor Models Market Overview
28.2. Middle East Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Models Market

29.1. Africa Tumor Models Market Overview
29.2. Africa Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Models Market Competitive Landscape And Company Profiles

30.1. Tumor Models Market Competitive Landscape
30.2. Tumor Models Market Company Profiles
- 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. LabCorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. WuXi AppTec Co Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Models Market Other Major And Innovative Companies

31.1. PerkinElmer Inc.
31.2. Pharmaron Beijing Co. Ltd.
31.3. The Jackson Laboratory
31.4. Taconic Biosciences Inc.
31.5. Cyagen Biosciences Inc.
31.6. Crown Bioscience Inc.
31.7. Champions Oncology Inc.
31.8. Reaction Biology Corporation
31.9. InSphero AG
31.10. Creative Biolabs Inc.
31.11. Oncodesign S.A.
31.12. Xentech S.A.
31.13. MIMETAS BV
31.14. Experimental Pharmacology and Oncology Berlin-Buch GmbH
31.15. Hera BioLabs Inc.

32. Global Tumor Models Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Models Market

34. Recent Developments In The Tumor Models Market

35. Tumor Models Market High Potential Countries, Segments and Strategies

35.1 Tumor Models Market In 2029 - Countries Offering Most New Opportunities
35.2 Tumor Models Market In 2029 - Segments Offering Most New Opportunities
35.3 Tumor Models Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer